Services Co., Ltd. THB 9 million (5) OKEA ASA THB -88 million. Management Discussion and Analysis of Business Operation for Q3/2019 Bangchak Corporation Plc. I 8 Summary of the Company and its subsidiaries

(Translation) NEP-AC 001/2563 26 February 2020 Subject: Management Discussion and Analysis for year ended December 31, 2019 To : The President The Stock Exchange of Thailand Operating Result NEP

EKH/CS/2020/030 11 August 2020 Subject: Management Discussion and Analysis for the Second Quarter 2020 results To Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public

August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries

% because the Company had net profit from operations of 1.04 million baht, decreased by 17.07 million baht from last year. Liquidity and Capital Sufficiency Analysis of Changes in Capital. As of 31st December

Microsoft Word - letY17EMD&A .doc (Translation) 23rd February 2018 Subject: Management Discussion and Analysis (MD&A) of year 2017 To: Managing Director of the Stock Exchange of Thailand Business

Investment (mai) Infraset Public Company Limted (the “Company”) hereby submitted the Management Discussion and Analysis of the year 2019 operating results, ending 31 December 2019. Details are as follows

Public Company Limted (the “Company”) hereby submitted the Management Discussion and Analysis of the 3rd Quarter 2019, ending 30 September 2019. Details are as follows: Operating Results Overview For the 3

& Analysis of Business Operation For the 2nd quarter ended June 30th, 2019 Management Discussion and Analysis of Business Operation for Q2/2019 Bangchak Corporation Plc. I 2 03 Table of Contents 06 08 22 25 27

analysis which the investment advisory company deliver to a customer; (4) an advice for a customer, except in case of using a tape recorder in giving advice which shall be kept for the period of not less